Lilly places $1b bet on AlzeCure’s Alzheimer’s project

A small Swedish biotech lands a potentially billion-dollar deal as the race shifts from treating Alzheimer’s to preventing it. Promising Alzheimer’s therapies have stumbled in clinical trials, billions of dollars have been spent chasing elusive biological targets and, despite recent progress, researchers are still wrestling with difficult realities. By the time symptoms appear, Alzheimer’s disease […] The post Lilly places $1b bet on AlzeCure’s Alzheimer’s project appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.